The purpose of this study was to identify the frequency, clinical effects, and suicide risk in comorbid fibromyalgia (FM) among patients with migraine.
Researchers surveyed patients with migraine who attended a headache clinic. All patients completed questionnaires containing demographics, headache profiles based on the International Classification of Headache Disorders, 2nd edition, FM questionnaires based on the modified 2010 American College of Rheumatology preliminary diagnostic criteria, Migraine Disability Assessment, Hospital Anxiety and Depression Scale, and Pittsburgh Sleep Quality Index. Suicide risk was evaluated by self-report of lifetime suicidal ideation and attempts.
READ FULL ARTICLE From www.neurology.org